These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 22639401)

  • 21. Immunosuppression and modulation in liver transplantation.
    Encke J; Uhl W; Stremmel W; Sauer P
    Nephrol Dial Transplant; 2004 Jul; 19 Suppl 4():iv22-5. PubMed ID: 15240845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High tacrolimus intra-patient variability is associated with graft rejection, and
    Del Bello A; Congy-Jolivet N; Danjoux M; Muscari F; Lavayssière L; Esposito L; Hebral AL; Bellière J; Kamar N
    World J Gastroenterol; 2018 Apr; 24(16):1795-1802. PubMed ID: 29713132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Post-liver transplantation immunosuppression: the song does not remain the same.
    Yoshida EM
    Can J Gastroenterol; 2002 Jan; 16(1):65-6. PubMed ID: 11826341
    [No Abstract]   [Full Text] [Related]  

  • 24. Preliminary immunosuppression withdrawal strategies with sirolimus in children with liver transplants.
    Sindhi R; Ganjoo J; McGhee W; Mazariegos G; Reyes J
    Transplant Proc; 2002 Aug; 34(5):1972-3. PubMed ID: 12176651
    [No Abstract]   [Full Text] [Related]  

  • 25. Does simultaneous lung-liver transplantation provide an immunologic advantage compared with isolated lung transplantation?
    Bhama JK; Pilewski JM; Zaldonis D; Fontes PA; DeVera ME; Shullo MA; Shigemura N; Bermudez CA; Toyoda Y; McCurry KR
    J Thorac Cardiovasc Surg; 2011 May; 141(5):e36-8. PubMed ID: 21497229
    [No Abstract]   [Full Text] [Related]  

  • 26. Early tacrolimus exposure after liver transplantation: relationship with moderate/severe acute rejection and long-term outcome.
    Rodríguez-Perálvarez M; Germani G; Papastergiou V; Tsochatzis E; Thalassinos E; Luong TV; Rolando N; Dhillon AP; Patch D; O'Beirne J; Thorburn D; Burroughs AK
    J Hepatol; 2013 Feb; 58(2):262-70. PubMed ID: 23023010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapamycin-based rescue therapy after chronic rejection in a pediatric liver transplant patient.
    Iglesias J; Ortega J; López JA; Sánchez L; Allende E; Asensio M; Margarit C
    Transpl Int; 2003 Oct; 16(10):765-7. PubMed ID: 12827229
    [No Abstract]   [Full Text] [Related]  

  • 28. Conversion from cyclosporine to tacrolimus in hepatic and renal transplantation.
    Yussim A; Shaharabani E; Mor E; Lustig S; Bar-Nathan N; Shmueli D; Sobolev V; Dorfman B; Or H; Shapira Z
    Transplant Proc; 1996 Dec; 28(6):3178-9. PubMed ID: 8962233
    [No Abstract]   [Full Text] [Related]  

  • 29. Sirolimus versus tacrolimus in kidney transplant recipients receiving mycophenolate mofetil and steroids: focus on acute rejection, patient and graft survival.
    Yang A; Wang B
    Am J Ther; 2015; 22(2):98-104. PubMed ID: 23921809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sirolimus and tacrolimus coefficient of variation is associated with rejection, donor-specific antibodies, and nonadherence.
    Pizzo HP; Ettenger RB; Gjertson DW; Reed EF; Zhang J; Gritsch HA; Tsai EW
    Pediatr Nephrol; 2016 Dec; 31(12):2345-2352. PubMed ID: 27286686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparison between tacrolimus (FK 506) and cyclosporin in immunosuppressive therapy after liver transplantation].
    Arnold JC; Theilmann L
    Z Gastroenterol; 1995 Oct; 33(10):624-5. PubMed ID: 7502559
    [No Abstract]   [Full Text] [Related]  

  • 32. Canadian national retrospective chart review comparing the long term effect of cyclosporine vs. tacrolimus on clinical outcomes in patients with post-liver transplantation hepatitis C virus infection.
    Yoshida EM; Lilly LB; Marotta PJ; Mason AL; Bilodeau M; Vaillancourt M
    Ann Hepatol; 2013; 12(2):282-93. PubMed ID: 23396740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Steroid-free liver transplantation in children.
    Reding R; Gras J; Sokal E; Otte JB; Davies HF
    Lancet; 2003 Dec; 362(9401):2068-70. PubMed ID: 14697809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prolongation of rat liver graft survival by splenectomy combined with low dose FK506 therapy.
    Kashu Y; Abe Y; Miyauchi K; Watanabe Y; Sato M; Sato N; Kimura S
    Artif Organs; 1996 Oct; 20(10):1116-9. PubMed ID: 8896731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sirolimus as primary immunosuppressant for calcineurin inhibitor-related renal insufficiency after liver transplantation.
    Yang YJ; Li LX; He Q; Fan H; Jin ZK; Lang R; Kou JT; Li P; Xie DH; Chen DZ
    Hepatobiliary Pancreat Dis Int; 2007 Aug; 6(4):376-8. PubMed ID: 17690032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of tacrolimus in the evolution of liver transplantation.
    Busuttil RW; Lake JR
    Transplantation; 2004 May; 77(9 Suppl):S44-51. PubMed ID: 15201686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sirolimus-based rescue therapy after rejection in liver transplantation.
    Lladó L; Fabregat J; Castellote J; Ramos E; Torras J; Serrano T; Figueras J; Rafecas A
    Clin Transplant; 2009; 23(1):89-95. PubMed ID: 19200220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liver transplantation: changing goals in immunosuppression.
    McMaster P; Gunson B; Min X; Afonso R; Bastos J
    Transplant Proc; 1998 Aug; 30(5):1819-21. PubMed ID: 9723295
    [No Abstract]   [Full Text] [Related]  

  • 39. Sirolimus vs azathioprine.
    Gleadle JM; Mason PD
    Lancet; 2000 Nov; 356(9243):1768-9. PubMed ID: 11095282
    [No Abstract]   [Full Text] [Related]  

  • 40. Alemtuzumab preconditioning allows steroid-calcineurin inhibitor-free regimen in live-donor kidney transplant.
    Refaie AF; Mahmoud KM; Ismail AM; Sheashaa HA; Kamal AI; Ghoneim MA
    Exp Clin Transplant; 2011 Oct; 9(5):295-301. PubMed ID: 21967254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.